Julia Rey

1.5k total citations · 1 hit paper
37 papers, 865 citations indexed

About

Julia Rey is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Julia Rey has authored 37 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Julia Rey's work include Breast Cancer Treatment Studies (9 papers), Brain Metastases and Treatment (7 papers) and Lung Cancer Research Studies (7 papers). Julia Rey is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Brain Metastases and Treatment (7 papers) and Lung Cancer Research Studies (7 papers). Julia Rey collaborates with scholars based in Germany, Switzerland and Spain. Julia Rey's co-authors include Vanesa España‐Romero, Enrique G. Artero, Jonatan R. Ruiz, Germán Vicente‐Rodríguez, Francisco B. Ortega, Carsten Denkert, Sibylle Loibl, Jenny Furlanetto, Peter A. Fasching and Claus Hanusch and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Julia Rey

35 papers receiving 842 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

2022 136 citations Sibylle Loibl, Andreas Schneeweiß et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Rey Germany	12	362	158	125	96	91	37	865
Torstein B. Rø Norway	20	268 0.7×	52 0.3×	93 0.7×	57 0.6×	94 1.0×	44	1.2k
Klaus Gasser Austria	9	112 0.3×	151 1.0×	30 0.2×	75 0.8×	75 0.8×	13	661
Hung‐Chih Hsu Taiwan	20	524 1.4×	204 1.3×	201 1.6×	209 2.2×	59 0.6×	105	1.2k
Huifang Liang United States	17	118 0.3×	116 0.7×	75 0.6×	116 1.2×	279 3.1×	46	1.2k
Rachel Conyers Australia	17	337 0.9×	253 1.6×	92 0.7×	80 0.8×	142 1.6×	56	927
Sau Wan Kan United Kingdom	11	215 0.6×	46 0.3×	41 0.3×	78 0.8×	110 1.2×	13	1.2k
Blanca Rueda‐Medina Spain	21	100 0.3×	139 0.9×	50 0.4×	81 0.8×	162 1.8×	78	1.2k
Thomas D. Ryan United States	20	233 0.6×	117 0.7×	25 0.2×	374 3.9×	91 1.0×	101	1.6k
Yuko Matsuda Japan	14	76 0.2×	69 0.4×	73 0.6×	159 1.7×	158 1.7×	48	1.1k
Anna Larsson Sweden	16	199 0.5×	84 0.5×	71 0.6×	133 1.4×	21 0.2×	39	697

Countries citing papers authored by Julia Rey

Since Specialization

Citations

This map shows the geographic impact of Julia Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Rey more than expected).

Fields of papers citing papers by Julia Rey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Rey. The network helps show where Julia Rey may publish in the future.

Co-authorship network of co-authors of Julia Rey

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Rey. A scholar is included among the top collaborators of Julia Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Rey. Julia Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bjelic‐Radisic, Vesna, Maike Schmidt, Julia Rey, et al.. (2025). 310P Quality of life with first-line ET + palbociclib vs standard mono-chemotherapy in high risk HER2-/HR+ mBC and indication for chemotherapy in the PADMA study. ESMO Open. 10. 104882–104882.

Loibl, S., Michael Untch, Jens Huober, et al.. (2025). 292MO Durvalumab in combination with neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Long-term analysis from the GeparNuevo trial. Annals of Oncology. 36. S303–S304. 1 indexed citations

Denk, Dominic, Anurag Singh, Herbert G. Kasler, et al.. (2025). Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature Aging. 5(11). 2309–2322. 2 indexed citations

Huebner, Hanna, Matthias Rübner, Andreas Schneeweiß, et al.. (2023). RNA expression levels from peripheral immune cells, a minimally invasive liquid biopsy source to predict response to therapy, survival and immune-related adverse events in patients with triple negative breast cancer enrolled in the GeparNuevo trial.. Journal of Clinical Oncology. 41(16_suppl). 1011–1011. 1 indexed citations

Laakmann, Elena, Elisa Agostinetto, Francesco Schettini, et al.. (2023). 208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC). ESMO Open. 8(1). 101397–101397. 1 indexed citations

Laakmann, Elena, Tjoung‐Won Park‐Simon, Rudolf Weide, et al.. (2022). Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC Registry. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 19(2). e34–e35. 1 indexed citations

Laakmann, Elena, Tanja Neunhöffer, Rudolf Weide, et al.. (2022). 170P Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry. Annals of Oncology. 33. S202–S203. 1 indexed citations

Loibl, Sibylle, Andreas Schneeweiß, Jens Huober, et al.. (2022). Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response. Annals of Oncology. 33(11). 1149–1158. 136 indexed citations breakdown →

Laakmann, Elena, Isabell Witzel, Tanja Neunhöffer, et al.. (2022). Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry. ESMO Open. 7(3). 100495–100495. 6 indexed citations

10.

Marmé, Frederik, Claus Hanusch, Jenny Furlanetto, et al.. (2022). 58O Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment. Annals of Oncology. 33. S148–S149. 26 indexed citations

11.

Denkert, Carsten, Andreas Schneeweiß, Julia Rey, et al.. (2022). Biomarkers for response to immunotherapy in triple-negative breast cancer: Differences between survival and pCR biomarkers.. Journal of Clinical Oncology. 40(16_suppl). 583–583. 4 indexed citations

12.

Marmé, Frederik, Elmar Stickeler, Jenny Furlanetto, et al.. (2021). Phase III postneoadjuvant study evaluating sacituzumab govitecan, an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA.. Journal of Clinical Oncology. 39(15_suppl). TPS602–TPS602. 16 indexed citations

13.

Reinisch, Mattea, Michael Untch, Toralf Reimer, et al.. (2020). 86P Patients (pts) preference for different administration methods of trastuzumab (T) in pts with HER2+ early breast cancer (BC) treated within the GAIN-2 trial. Annals of Oncology. 31. S44–S44. 1 indexed citations

14.

Ohlendorf, Daniela, et al.. (2020). Influence of typical handball characteristics on upper body posture and postural control in male handball players. BMC Sports Science Medicine and Rehabilitation. 12(1). 4–4. 7 indexed citations

15.

Hausmann, Johannes, Alica Kubesch, Julia Rey, et al.. (2019). Quality of life of patients with head and neck cancer after prophylactic percutaneous-gastrostomy. European Journal of Clinical Nutrition. 74(4). 565–572. 2 indexed citations

16.

Holzgreve, Fabian, et al.. (2018). The office work and stretch training (OST) study: an individualized and standardized approach for reducing musculoskeletal disorders in office workers. Journal of Occupational Medicine and Toxicology. 13(1). 37–37. 23 indexed citations

17.

Friedrich‐Rust, Mireen, Sebastian K.G. Maier, Florian Seeger, et al.. (2017). Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study. PLoS ONE. 12(10). e0186720–e0186720. 22 indexed citations

18.

Rey, Julia, et al.. (2012). Reconstrucción y datación arqueológica de las secuencias evolutivas holocenas en la Hoya de Huesca: el yacimiento del Cabezo del Lobo. 6(1). 111–122.

19.

España‐Romero, Vanesa, Francisco B. Ortega, Germán Vicente‐Rodríguez, et al.. (2010). Elbow Position Affects Handgrip Strength in Adolescents: Validity and Reliability of Jamar, DynEx, and TKK Dynamometers. The Journal of Strength and Conditioning Research. 24(1). 272–277. 209 indexed citations

20.

Froehlich, Florian, Julia Rey, C. Schneider, et al.. (2002). Do Explicit Appropriateness Criteria Enhance the Diagnostic Yield of Colonoscopy?. Endoscopy. 34(5). 360–368. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact